Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin E supplements may slow coronary artery disease progression -- JAMA study.

This article was originally published in The Tan Sheet

Executive Summary

VITAMIN E SUPPLEMENTATION MAY SLOW PROGRESSION OF CORONARY ARTERY DISEASE, a subgroup analysis of the data-base acquired in the Cholesterol Lowering Atherosclerosis Study (CLAS) suggests. CLAS was a randomized, placebo-controlled, serial angiographic clinical trial designed to evaluate the effect of cholesterol-lowering agents colestipol and niacin on coronary artery disease progression. The study, supported by the National Heart, Lung and Blood Institute, was published in the June 21 Journal of the American Medical Association.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083974

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel